ADmit Therapeutics
ES-MF-000042518 · Spain · Sant Feliu de Llobregat
ADmit Therapeutics is registered in the European database on medical devices as a manufacturer, with 8 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
Devices declared under this manufacturer
- MAP-AD Test Oligos - Oligo1-Fw
- MAP-AD Test Oligos - Oligo1-Rev
- MAP-AD Test Oligos - Oligo2-Fw
- MAP-AD Test Oligos - Oligo2-Rev
- MAP-AD Test Software - Backend
- MAP-AD Test Software - Frontend
Catalogue references include AD001-01, AD001-02, AD001-03, AD001-04, AD002.
European nomenclature codes declared: W0106010201, W02050192.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 8 |
| Country of registration | Spain |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 8 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. ADmit Therapeutics was not found in either the U.S. or the Canadian register.